Open Access
Experimental and clinical aspects of the pathogenesis of endotoxin shock
Author(s) -
N. R. Ivanov,
B. Z. Shankman
Publication year - 1984
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj89402
Subject(s) - septic shock , antibiotics , medicine , disease , shock (circulatory) , immunology , intensive care medicine , infectious disease (medical specialty) , pathogenesis , diagnostic test , infectious agent , sepsis , pathology , biology , pediatrics , microbiology and biotechnology
The occurrence of a shock-like state in connection with an infectious disease was first reported by Laennek in 1831. More specifically, this relationship was established in 1899 [46]. The absence of a noticeable decrease in the frequency of recorded endotoxin shock in humans is due to a number of factors, the most important among which are the following: a) improvement in the diagnosis of endotoxin shock, made possible by the use of sophisticated diagnostic equipment; b) familiarity of specialists of various profiles with this nosological form; c) an increase in the life expectancy of patients with severe pathology and a decrease in general and immunological reactivity; d) the use of immunosuppressants and cytostatic drugs for allergies, malignant neoplasms, which facilitates the development of infectious pathology; e) frequent obstetric pathology, accompanied by the birth of children with reduced resistance; f) widespread use of antibiotic therapy, leading to the emergence of antibiotic-resistant microbes; it should also be noted here that when treating septic foci and infectious diseases with antibiotics, there is a danger of massive entry into the bloodstream of endotoxins released from dead microorganisms; g) carrying out complex diagnostic manipulations and surgical operations that open the entrance gates for infection.